Global ECMO Machine Market is valued at approximately USD 500 million in 2020 and is anticipated to grow with a healthy growth rate of more than 4.9 % over the forecast period 2021-2027. ECMO Machine is a life support machine. People who need ECMO have a severe and life-threatening illness that stops their heart or lungs from working properly. For example, ECMO is used during life-threatening conditions such as severe lung damage from infection or shock after a massive heart attack. Growing adoption of ECMO in lung transplantation procedures, increasing prevalence of cardiovascular and respiratory diseases has led to the adoption of ECMO Machine across the forecast period. For Instance: As per the WHO, An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Also, with the increasing survival rates, the adoption & demand for ECMO Machine is likely to increase the market growth during the forecast period. However, high costs impede the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global ECMO Machine market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as growing geriatric population, increasing disposable income would create lucrative growth prospects for the ECMO Machine market across Asia Pacific region.

Major market players included in this report are:
ABIOMED
Fresenius Medical care AG & Co.
KGaA (Germany)
Getinge Group (Sweden)
Medtronic plc (US)
Terumo Cardiovascular Systems Corporation
NIPRO CORPORATION
LIVANOVA PLC
EUROSETS S.R.L.
CYTOSORBENTS CORPORATION
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
ECMO Machine
Software
By Component:
Pumps
Oxygenators
Controllers
Cannul
Assessories
By Outlook:
Veno-Venous
Veno-Arterials
Arterio-Venous
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global ECMO Machine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

ABIOMED
Fresenius Medical care AG & Co.
KGaA (Germany)
Getinge Group (Sweden)
Medtronic plc (US)
Terumo Cardiovascular Systems Corporation
NIPRO CORPORATION
LIVANOVA PLC
EUROSETS S.R.L.
CYTOSORBENTS CORPORATION